|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Defining incident vertebral deformities in population studies:a comparison of morphometric criteria显示文摘 | Lunt M Ismail AA Felsenberg D | | 0，，10： | 1 |
| 2 | The bone quality framework: detemubabts if bone strength and their interrelatioships, and implications for osteoporosis management显示文摘 | Felsenberg D Boonen S | 2005 | Clin Ther2005，27，： | 1 |
| 3 | Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture:results from the European Prospective Study (E-POS)显示文摘 | Lunt M O' Neill T Felsenberg D | 2003 | Bone2003，33，4： | 1 |
| 4 | Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture:resuhs from the European Prospective Osteoporosis Study (EPOS) 显示文摘 | Lunt M O' Neill TW Felsenberg D | 2003 | Bone2003，33，4： | 1 |
| 5 | Effects of long term strontium ranelate treatment on the risk of non-vertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year,randomized,placebo-controlled trail显示文摘 | Reginster JY Felsenberg D Boonen S | 2008 | Arthritis Rheum2008，58，6： | 1 |
| 6 | Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures:a population survey of older men and women显示文摘 | Leidig-Bruckner G Limberg B Felsenberg D | 2000 | Osteoporos Int2000，11，： | 1 |
| 7 | Acute physiological effects of exhaustive whole-body vibration exercise in man 显示文摘 | Rittweger J Belier G Felsenberg D | 2000 | Clinical Physiology2000，20，2： | 1 |
| 8 | Oral iban ~ onate significantly reduces the risk of vertebral fractures of greater severity after 1,2,and 3 years in postmenopausal women with osteoporosis显示文摘 | Felsenberg D Miller P Armbrecht G | 2005 | Bone2005，37，5： | 1 |
| 9 | Oral weekly ibandronate prevents bone loss in postmenopausal women显示文摘 | Tanko LB Felsenberg D Czerwinski E | 2003 | J Inter Med2003，254，2： | 1 |
| 10 | Oral ibandronate significandy reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis显示文摘 | Felsenberg D Miller P Armbrecht G | 2005 | Bone2005，37，5： | 1 |
| 11 | How Strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis显示文摘 | Marie P J Felsenberg D Brandi ML | 2011 | Osteoporos lnt2011，22，6： | 1 |
| 12 | Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor: induced bone disease显示文摘 | Dunstan C R Felsenberg D Seibel M J | 2007 | Nat Clin Pract Oncol2007，4，1： | 1 |
| 13 | Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss显示文摘 | Ismail AA Cooper C Felsenberg D | 1999 | Osteoporos Int1999，9，3： | 1 |
| 14 | Association between incident and baseline vertebral fractures in European women: vertebral frac- ture assessment in the Osteoporosis and Ultrasound Study (OPUS)显示文摘 | Ferrar L Roux C Felsenberg D | 2012 | Osteoporosis International2012，23，1： | 1 |
| 15 | Oral weekly iban- dronate prevents bone loss in postmenopausal women显示文摘 | Tanko LB Felsenberg D Czerwifiski E | 2003 | J Intern Med2003，254，2： | 1 |
| 16 | Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis:Results of a five-year, randomized, placebo-controlled trial显示文摘 | Riginster JY Felsenberg D Boonen S | 2008 | Arthritis Rheum2008，58，： | 1 |
| 17 | The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study显示文摘 | O'Neill TW Felsenberg D Varlow J | 1996 | J Bone Miner Res1996，11，7： | 1 |
| 18 | Number and type of vertebral deformities:epidemiological characteristics and relation to back pain and height loss显示文摘 | Ismail AA Cooper C Felsenberg D | 1999 | Osteoporos Int1999，9，： | 1 |
| 19 | Association between incident and baseline vertebral fractures in European women : vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS) 显示文摘 | Ferrar L Roux C Felsenberg D | 2012 | Osteoporos Int2012，23，1： | 1 |
| 20 | Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass显示文摘 | Felsenberg D Bock O B?rst H | | 0，，01： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员